Ftse Mib
38.308,80
0,00%
DAX
22.678,41
0,05%
S&P 500
5.599,30
0,49%
NASDAQ
17.648,45
1,22%
Bitcoin
83.024,91
-0,78%
Pepperstone
Advertisement
Registration Strip Icon for monitor Monitora più quotazioni in tempo reale dalle principali borse, come Borsa Italiana, NASDAQ, NYSE, AMEX, Bovespa e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Ventyx Biosciences Inc (VTYX) Ventyx Biosciences Inc (VTYX) Notizie

Ventyx Biosciences Inc

VTYX
1,48
0,02 (1,37%)
Pre Mercato
Ultimo aggiornamento: 10:56:47
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
12/3/202521:05EDGAR2Form SCHEDULE 13D/A - General Statement of Acquisition of..
28/2/202514:15EDGAR2Form S-8 - Securities to be offered to employees in employee..
27/2/202523:21EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
27/2/202522:11EDGAR2Form 8-K - Current report
27/2/202522:05GLOBEVentyx Biosciences Reports Fourth Quarter and Full Year 2024..
18/2/202514:00GLOBEVentyx Biosciences Announces Presentation of Data from the..
05/2/202514:00GLOBEVentyx Biosciences to Participate in the Oppenheimer 35th..
14/1/202515:15EDGAR2Form 8-K - Current report
14/1/202514:00GLOBEVentyx Biosciences Highlights 2025 Pipeline Strategy and..
04/1/202500:57EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/1/202500:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/1/202500:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/1/202500:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/12/202423:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/12/202422:46EDGAR2Form 144 - Report of proposed sale of securities
20/12/202400:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/12/202400:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/12/202400:48EDGAR2Form 144 - Report of proposed sale of securities
11/12/202423:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/11/202403:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/11/202422:59EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
07/11/202423:13EDGAR2Form S-3 - Registration statement under Securities Act of..
07/11/202422:58EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/11/202422:10EDGAR2Form 8-K - Current report
07/11/202422:05GLOBEVentyx Biosciences Reports Third Quarter 2024 Financial..
15/10/202414:00GLOBEVentyx Biosciences Presents New 52-Week Results from the..
23/9/202414:18EDGAR2Form 8-K - Current report
23/9/202414:00GLOBEVentyx Biosciences Announces $27 Million Strategic..
09/9/202422:47EDGAR2Form 3 - Initial statement of beneficial ownership of..
06/9/202414:00GLOBEVentyx Biosciences Announces Initiation of Dosing in a Phase..
30/8/202414:15EDGAR2Form 8-K - Current report
30/8/202414:00GLOBEVentyx Biosciences Announces Departure of Chief Financial..
28/8/202414:00GLOBEVentyx Biosciences to Participate in Two Upcoming Investor..
13/8/202422:48EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/8/202422:35EDGAR2Form 3 - Initial statement of beneficial ownership of..
08/8/202422:15EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/8/202422:05EDGAR2Form 8-K - Current report
08/8/202422:01GLOBEVentyx Biosciences Reports Second Quarter 2024 Financial..
29/7/202414:00GLOBEVentyx Biosciences Announces Results from the Phase 2 Trial..
11/6/202422:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/6/202422:05EDGAR2Form 8-K - Current report
05/6/202422:21EDGAR2Form 8-K - Current report
05/6/202422:01GLOBEVentyx Biosciences Announces Positive Preclinical Data for..
16/5/202422:05GLOBEVentyx Biosciences to Participate in Three Upcoming Investor..
16/5/202414:12EDGAR2Form 8-K - Current report
16/5/202414:00GLOBEVentyx Biosciences Announces Appointment of Matthew Moore as..
09/5/202422:16EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/5/202422:06EDGAR2Form 8-K - Current report
09/5/202422:01GLOBEVentyx Biosciences Reports First Quarter 2024 Financial..
02/5/202422:05GLOBEVentyx Biosciences to Report First Quarter 2024 Financial..
Apertura: Min: Max:
Chiusura: 1,46

La tua Cronologia

NASDAQ
VTYX
Ventyx Biosciences
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network

Rimuovi gli annunci

Iscriviti per un'esperienza senza pubblicità

Nessuna pubblicità

Prova adesso

Conserva gli annunci